Publikationsliste 2014

Hier finden Sie eine Liste der 2014 durch Mitarbeiter der Abteilung für Kardiologie als Erstautor publizierten Originalarbeiten.

Right ventricular dysfunction, but not tricuspid regurgitation, is associated with outcome late after left heart valve procedure.
Kammerlander AA, Marzluf BA, Graf A, Bachmann A, Kocher A, Bonderman D, Mascherbauer J.J Am Coll Cardiol. 2014 Dec 23;64(24):2633-42.

Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.
Krychtiuk KA, Kastl SP, Pfaffenberger S, Pongratz T, Hofbauer SL, Wonnerth A, Katsaros KM, Goliasch G, Gaspar L, Huber K, Maurer G, Dostal E, Oravec S, Wojta J, Speidl WS.Atherosclerosis. 2014 Dec;237(2):589-96. 

Comparison of NOGA endocardial mapping and cardiac magnetic resonance imaging for determining infarct size and infarct transmurality for intramyocardial injection therapy using experimental data.
Pavo N, Jakab A, Emmert MY, Strebinger G, Wolint P, Zimmermann M, Ankersmit HJ, Hoerstrup SP, Maurer G, Gyöngyösi M.PLoS One. 2014 Nov 19;9(11):e113245. 

A new coronary artery disease grading system correlates with numerous routine parameters that were associated with atherosclerosis: a grading system for coronary artery disease severity.
Sponder M, Fritzer-Szekeres M, Marculescu R, Litschauer B, Strametz-Juranek J.Vasc Health Risk Manag. 2014 Nov 7;10:641-7

Extended-release oral treprostinil for the treatment of pulmonary arterial hypertension.
Skoro-Sajer N, Lang I.Expert Rev Cardiovasc Ther. 2014 Dec;12(12):1391-9. 

Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls.
Pezawas T, Diedrich A, Winker R, Robertson D, Richter B, Wang L, Byrne DW, Schmidinger H.Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1101-8 

On-line visualization of ischemic burden during repetitive ischemia/reperfusion.Pavo N, Emmert MY, Giricz Z, Varga ZV, Ankersmit HJ, Maurer G, Hoerstrup SP, Ferdinandy P, Wu JC, Gyöngyösi M.JACC Cardiovasc Imaging. 2014 Sep;7(9):956-8

The role of biomarkers in valvular heart disease: focus on natriuretic peptides. Bergler-Klein J, Gyöngyösi M, Maurer G.Can J Cardiol. 2014 Sep;30(9):1027-34

Interplay between genetic and clinical variables affecting platelet reactivity and cardiac adverse events in patients undergoing percutaneous coronary intervention. Siller-Matula JM, Lang IM, Neunteufl T, Kozinski M, Maurer G, Linkowska K, Grzybowski T, Kubica J, Jilma B.PLoS One. 2014 Jul 22;9(7):e102701

Endostatin and physical exercise in young female and male athletes and controls.Sponder M, Sepiol K, Lankisch S, Priglinger M, Kampf S, Litschauer B, Fritzer-Szekeres M, Strametz-Juranek J.Int J Sports Med. 2014 Dec;35(13):1138-42 

Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences.Pavo N, Charwat S, Nyolczas N, Jakab A, Murlasits Z, Bergler-Klein J, Nikfardjam M, Benedek I, Benedek T, Pavo IJ, Gersh BJ, Huber K, Maurer G, Gyöngyösi M.J Mol Cell Cardiol. 2014 Oct;75:12-24

A prediction tool for initial out-of-hospital cardiac arrest survivors. Aschauer S, Dorffner G, Sterz F, Erdogmus A, Laggner A.Resuscitation. 2014 Sep;85(9):1225-31

Blood and urine levels of heavy metal pollutants in female and male patients with coronary artery disease.Sponder M, Fritzer-Szekeres M, Marculescu R, Mittlböck M, Uhl M, Köhler-Vallant B, Strametz-Juranek J.Vasc Health Risk Manag. 2014 May 13;10:311-7

C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.Koller L, Kleber M, Goliasch G, Sulzgruber P, Scharnagl H, Silbernagel G, Grammer T, Delgado G, Tomaschitz A, Pilz S, März W, Niessner A.Eur J Heart Fail. 2014 Jul;16(7):758-66

Preclinical randomised safety, efficacy and physiologic study of the silicon dioxide inert-coated Axetis and bare metal stent: short-, mid- and long-term outcome.Pavo N, Syeda B, Bernhart A, Szentirmai E, Hemetsberger R, Samaha E, Plass C, Zlabinger K, Pavo IJ, Petrasi Z, Petnehazy O, Hoerstrup SP, Maurer G, Gyöngyösi M.EuroIntervention. 2014 Apr 29. 

Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction. Adlbrecht C, Huber K, Reynolds HR, Carvalho AC, Džavík V, Steg PG, Liu L, Marino P, Pearte CA, Rankin JM, White HD, Lamas GA, Hochman JS.Int J Cardiol. 2014 Jun 1;174(1):90-5 

Single, remote-magnetic catheter approach for pulmonary vein isolation in patients with paroxysmal and non-paroxysmal atrial fibrillation. Pezawas T, Ristl R, Bilinski M, Schukro C, Schmidinger H.Int J Cardiol. 2014 Jun 1;174(1):18-24

Prognostic value of culprit site neutrophils in acute coronary syndrome.Distelmaier K, Winter MP, Dragschitz F, Redwan B, Mangold A, Gleiss A, Perkmann T, Maurer G, Adlbrecht C, Lang IM.Eur J Clin Invest. 2014;44(3):257-65

Peri-interventional endothelin--a receptor blockade improves long-term outcome in patients with ST-elevation acute myocardial infarction.Adlbrecht C, Wurm R, Humenberger M, Andreas M, Redwan B, Distelmaier K, Klappacher G, Lang IM.Thromb Haemost. 2014 Jul 3;112(1):176-82

Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection.Eslam RB, Burian A, Vila G, Sauermann R, Hammer A, Frenzel D, Minichmayr IK, Kloft C, Matzneller P, Oesterreicher Z, Zeitlinger M.J Clin Pharmacol. 2014 Sep;54(9):1058-62

Association between the rs342293 polymorphism and adverse cardiac events in patients undergoing percutaneous coronary intervention.Siller-Matula JM, Arbesu I, Jilma B, Maurer G, Lang IM, Mannhalter C.Thromb Haemost. 2014 Jun;111(6):1060-6

Effects of AV-delay optimization on hemodynamic parameters in patients with VDD pacemakers.Krychtiuk KA, Nürnberg M, Volker R, Pachinger L, Jarai R, Freynhofer MK, Wojta J, Huber K, Weiss TW.Wien Klin Wochenschr. 2014 May;126(9-10):270-7

Splenectomy is modifying the vascular remodeling of thrombosis.Frey MK, Alias S, Winter MP, Redwan B, Stübiger G, Panzenboeck A, Alimohammadi A, Bonderman D, Jakowitsch J, Bergmeister H, Bochkov V, Preissner KT, Lang IM.J Am Heart Assoc. 2014 Feb 28;3(1):e000772

Effects of endothelin A receptor blockade in patients with ST-elevation acute coronary syndrome--a rhythmologic substudy.Adlbrecht C, Wurm R, Pezawas T, Andreas M, Redwan B, Distelmaier K, Kaider A, Lang IM.Life Sci. 2014 Nov 24;118(2):430-4

Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension. Alias S, Redwan B, Panzenböck A, Winter MP, Schubert U, Voswinckel R, Frey MK, Jakowitsch J, Alimohammadi A, Hobohm L, Mangold A, Bergmeister H, Sibilia M, Wagner EF, Mayer E, Klepetko W, Hölzenbein TJ, Preissner KT, Lang IM. Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):810-9

Changing perceptions in pulmonary hypertension.Gerges C, Lang IM.Lancet Respir Med. 2014 Jan;2(1):21-3

Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction.Pavo N, Zimmermann M, Pils D, Mildner M, Petrási Z, Petneházy Ö, Fuzik J, Jakab A, Gabriel C, Sipos W, Maurer G, Gyöngyösi M, Ankersmit HJ.Biomaterials. 2014 Apr;35(11):3541-50

Association of thrombin generation potential with platelet PAR-1 regulation and P-selectin expression in patients on dual antiplatelet therapy.Badr Eslam R, Posch F, Lang IM, Gremmel T, Eichelberger B, Ay C, Panzer S.J Cardiovasc Transl Res. 2014 Feb;7(1):126-32

Clinical implications of drug-drug interactions with P2Y12 receptor inhibitors.Siller-Matula JM, Trenk D, Krähenbühl S, Michelson AD, Delle-Karth G.J Thromb Haemost. 2014 Jan;12(1):2-13

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention. Krenn L, Kopp C, Glogar D, Lang IM, Delle-Karth G, Neunteufl T, Kreiner G, Kaider A, Bergler-Klein J, Khorsand A, Nikfardjam M, Laufer G, Maurer G, Gyöngyösi M.Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1029-39

Exercise increases serum endostatin levels in female and male patients with diabetes and controls.Sponder M, Dangl D, Kampf S, Fritzer-Szekeres M, Strametz-Juranek J.Cardiovasc Diabetol. 2014 Jan 6;13:6

Selexipag for the treatment of pulmonary arterial hypertension.Skoro-Sajer N, Lang IM.Expert Opin Pharmacother. 2014 Feb;15(3):429-36

Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy.Skoro-Sajer N, Marta G, Gerges C, Hlavin G, Nierlich P, Taghavi S, Sadushi-Kolici R, Klepetko W, Lang IM.Thorax. 2014 Feb;69(2):116-22